RPS6KA3 and central nervous system cancer: First, by comparison of the brain samples in the large “Human Body Map” with the three largest, best annotated public glioma datasets, we observed that RSK2 mRNA expression is significantly lower in normal brain tissue than in human glioma samples (Figure 7), in concordance with a tumor-promoting role for RSK2 in glioma.